Bio-Rad Laboratories Inc. Cl A | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
609
698
790
844
761
850
Total Accounts Receivable
423
378
391
372
465
392
Inventories
501
471
490
525
595
584
Other Current Assets
215
170
105
103
156
197
Total Current Assets
1,748
1,716
1,778
1,845
1,977
2,023
Net Property, Plant & Equipment
429
429
438
489
493
509
Total Investments and Advances
378
389
720
831
1,028
2,658
Intangible Assets
784
755
710
639
680
353
Other Assets
50
52
65
48
95
68
Total Assets
3,389
3,341
3,710
3,851
4,273
5,611
ST Debt & Current Portion LT Debt
-
-
-
-
2
Accounts Payable
149
129
122
133
135
Income Tax Payable
34
35
29
28
40
Other Current Liabilities
304
283
289
310
327
Total Current Liabilities
487
447
441
471
503
Long-Term Debt
436
436
434
434
435
Provision for Risks & Charges
-
-
6
63
74
Deferred Taxes
162
155
233
225
222
Other Liabilities
117
119
105
77
109
Total Liabilities
1,202
1,156
1,219
1,271
1,343
Common Equity (Total)
2,187
2,185
2,491
2,579
2,930
Total Shareholders' Equity
2,187
2,185
2,491
2,579
2,930
Total Equity
2,187
2,185
2,491
2,579
2,930
Liabilities & Shareholders' Equity
3,389
3,341
3,710
3,851
4,273

About Bio-Rad Laboratories

View Profile
Address
1000 Alfred Nobel Drive
Hercules California 94547
United States
Employees -
Website http://www.bio-rad.com
Updated 07/08/2019
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments.